Silk Road Medical to Present at Upcoming Investor Conferences
Silk Road Medical (Nasdaq: SILK) announced its participation in upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Silk Road Medical (Nasdaq: SILK) announced its participation in upcoming investor conferences. The presentations will occur at:
- Stifel 2022 Healthcare Conference on November 15 at 10:20 a.m. Eastern Time
- 4th Annual Wolfe Research Healthcare Conference on November 16 at 1:20 p.m. Eastern Time
- 34th Annual Piper Sandler Healthcare Conference on November 30 at 3:00 p.m. Eastern Time
Webcasts of the presentations will be available in the “Investors” section of their website.
Details
News Market Reaction – SILK
The recorded move for SILK in the trading session of this news was +0.16%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SUNNYVALE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that management will present at the following investor conferences.
- Stifel 2022 Healthcare Conference
Presentation on Tuesday, November 15 at 10:20 a.m. Eastern Time
- 4th Annual Wolfe Research Healthcare Conference
Presentation on Wednesday, November 16 at 1:20 p.m. Eastern Time
- 34th Annual Piper Sandler Healthcare Conference
Presentation on Wednesday, November 30 at 3:00 p.m. Eastern Time
Interested parties may access a live and archived webcast of each presentation on the “Investors” section of the company’s website at: https://investors.silkroadmed.com/.
About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.
Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com
Media:
Michael Fanucchi
Silk Road Medical
mfanucchi@silkroadmed.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.